<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pharmaceutics-12-00688-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">pharmaceutics-12-00688-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Anti-oxidant activity of SAAs.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SAAs</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Assay</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SDS (anionic) 
     <break/>Tween-20 (non-ionic)
     <break/>CTAB (cationic) surfactants, O/W emulsions
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipid hydroperoxides</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ lipid oxidation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B71-pharmaceutics-12-00688" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SDS (anionic) 
     <break/>Tween-80 (non-ionic) surfactants, O/W emulsions
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propanal/hydroperoxides</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ lipid oxidation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B83-pharmaceutics-12-00688" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tween-20 (non-ionic)
     <break/>Tween-20 (non-ionic/Span-20 (co-surfactant) mixture, O/W emulsions
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oxygen uptake, conjugated dienes (CD) and formation of volatile compounds</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ lipid oxidation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B84-pharmaceutics-12-00688" ref-type="bibr">84</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tween-20/Tween-80
     <break/>(non-ionic) surfactants
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DCFH-DA / Flow Cytometry</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ ROS productionin PMA/H
     <sub>2</sub>O
     <sub>2</sub>-treated human neutrophils
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B86-pharmaceutics-12-00688" ref-type="bibr">86</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS/Vitamin E TPGS)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TBARS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ ROS production</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B94-pharmaceutics-12-00688" ref-type="bibr">94</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkyl succinylatedtyrosol synthetic amphiphilic lipids</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH radical scavenging, TBARS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH radicals
     <break/>↓ lipid oxidation
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B96-pharmaceutics-12-00688" ref-type="bibr">96</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Erythorbyl laurate (6-O-lauroyl-erythorbic acid),</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TBARS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ lipid oxidation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B99-pharmaceutics-12-00688" ref-type="bibr">99</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">single N-quaternized (QCS) and double N-diquaternized (DQCS) chitosan</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, hydroxyl, superoxide radicals, reducing power</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH, hydroxyl and superoxide radicals
     <break/>↑ reducing power
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B102-pharmaceutics-12-00688" ref-type="bibr">102</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucosyl- and glucuronosyl alkyl gallates derivatives</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, FRAP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH,
     <break/>↑ rates of reduction of Fe
     <sup>3+</sup> to Fe
     <sup>2+</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B103-pharmaceutics-12-00688" ref-type="bibr">103</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">κ-carrageenan oligosaccharides,
     <break/>oversulfated (SD)
     <break/>low acetylated (LAD)
     <break/>high acetylated (HAD) 
     <break/>phosphorylated (PD) 
     <break/>κ-carrageenans
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, superoxide anion, hydroxyl radical scavenging activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH, superoxide and hydroxyl radicals </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B104-pharmaceutics-12-00688" ref-type="bibr">104</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">κ-ca3000 + CP complex
     <break/>(κ-carrageenan 3kD+ collagen peptides)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DCFH-DA/FlowCytometry</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ ROS production
     <break/>Protection of HaCaT abd MEF cells from UV-induced cell death
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B105-pharmaceutics-12-00688" ref-type="bibr">105</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Rhamnolipids</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B106-pharmaceutics-12-00688" ref-type="bibr">106</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, FRAP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH,
     <break/>↑ rates of reduction of Fe3+ to Fe2+
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B107-pharmaceutics-12-00688" ref-type="bibr">107</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TBARS, Lipid hydroperoxides </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ lipid oxidation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B108-pharmaceutics-12-00688" ref-type="bibr">108</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sophorolipids</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, FRAP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPH,
     <break/>↑ rates of reduction of Fe3+ to Fe2+
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B109-pharmaceutics-12-00688" ref-type="bibr">109</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MELs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH, superoxide anion scavenging activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ formation of DPPHand superoxide radicals </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B110-pharmaceutics-12-00688" ref-type="bibr">110</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>SDS: sodium dodecyl sulfate; CTAB: cetyl trimethyl ammonium bromide; O/W: oil in water; ROS: reactive oxygen species; PMA: phorbol myristate acetate; CP: collagen peptide; MELs: mannosylerythritol lipids; DCFH-DA: dichloro-dihydro-fluorescein diacetate; TBARS: thiobarbituric acid reactive substances; FRAP: ferric reducing antioxidant power; DPPH: 2,2-dipheny;-1-picrylhydrazyl; ↑: increased; ↓ decreased.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
